Circulatory biomarkers for Idiopathic Pulmonary Fibrosis: improving patient outcomes

特发性肺纤维化的循环生物标志物：改善患者预后

• 批准号: nhmrc : GNT1147776
• 负责人: A/Pr Christopher Grainge
• 金额: $ 83万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/circulatory-biomarkers-idiopathic-patient-outcomes/1348849
• 关键词: Circulatory; biomarkers; Idiopathic; Pulmonary; Fibrosis

We are going to find molecules in the blood that would improve the diagnosis and treatment of a lung condition called Idiopathic Pulmonary Fibrosis (IPF). The project brings together well characterized patients from the Australian IPF registry, blood samples we have collected from them and cutting edge technologies to complete this project.

我们正在寻找血液中的分子，以改善一种名为特发性肺纤维化(IPF)的肺部疾病的诊断和治疗。该项目汇集了来自澳大利亚IPF登记处的具有良好特征的患者、我们从他们那里收集的血液样本以及完成该项目的尖端技术。